1. Articles from Kelsey MacElroy

    1-1 of 1
    1. ISS Updates its Voting Policies

      ISS Updates its Voting Policies

      On November 12, Institutional Shareholder Services (“ISS”) published its annual policy updates in its 2021 global proxy voting guidelines, which are effective for shareholder meetings held on or after February 1, 2021. Social and environmental issues, board diversity, shareholder litigation rights and COVID-19 recovery era policies emerged as ISS’ main areas of focus for its policy updates...

      Read Full Article
    1-1 of 1
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics in the News

    1. (1 articles) Board Diversity
    2. (1 articles) ISS
    3. (1 articles) social issues
    4. (1 articles) overboarding
    5. (1 articles) Proxy Voting
    6. (1 articles) sexual harassment
    7. (1 articles) Delaware
    8. (1 articles) Institutional Shareholder Services
    9. (1 articles) arbitration
    10. (1 articles) COVID
  3. Popular Articles

  4. Picture Gallery

    ISS Updates its Voting Policies Wetherspoon Boss Accuses Fidelity of Hypocrisy in Board Spat Jamieson Wellness Inc. Announces Appointment of New Director Elizabeth Holmes Points Fingers at Others and Says She Was a Believer SM Energy Announces The Appointment Of Anita M. Powers To The Company's Board Of Directors II-VI Appoints CEO Chuck Mattera to Chairman Role, Makes Other Board Announcements AcelRx Pharmaceuticals Announces the Appointment of Jill Broadfoot to its Board of Directors ITC Holdings Corp. Makes Two New Appointments to Board of Directors Paychex Board of Directors Announce Appointments of Martin Mucci as Board Chair and CEO and John Gibson as President and Chief Operating Officer A Tech Whistle-Blower Helps Others Speak Out ProPetro Avoids Fine in Executive Perk Case; ex-CEO to Pay $195K The Poison Pill, Long Hated by Investors, Gets New Love in Japan